Introduction
One of the main complications of liver cirrhosis is portal hypertension with variceal hemorrhage ( fi g. 1 ).
For many years local hemostasis has been the preferred strategy to stop bleeding. In the 1970s, this was almost completely replaced by fl exible endoscopy. Since then the scope has been used to achieve three different goals: prophylaxis of fi rst bleeding; stasis of acute bleeding, and prevention of recurrent bleeding.
For each of these situations further approaches are available which act not only locally but also address systemic pathophysiological derangements such as portosystemic shunts, drugs that reduce the portal pressure or antibiotics aiming at the intestinal microfl ora that induces systemic hemodynamic reactions in the patient with liver cirrhosis. In some situations, endoscopy is combined with these treatments.
Endoscopy allows application of three different tools to stop or to prevent bleeding: injection of sclerosants or glue and positioning of rubber bands over the collaterals. We present data on the fact that, in most cases, injection sclerotherapy has been abandoned in favor of ligation in the setting of acute bleeding or prophylaxis of fi rst and recurrent bleeding, respectively, and that injection of glue is reserved for specifi c situations.
Technique
Ligation is performed with a fl exible endoscope. The varix is aspirated into a cylinder affi xed to the tip of the scope. Then, by pulling a trip wire running through the biopsy channel of the scope, a rubber ring is released that strangulates the aspirated vessel ( fi g. 2 ) leading to thrombosis and obliteration of this special varix. After 5-10 days the rubber bands and parts of obliterated varices fall off and leave behind shallow ulcers. The most critical part of the whole procedure is incomplete aspiration of a large varix and loss of the rubber band after some days without complete thrombosis. This may cause very dangerous bleeding [1] . Two to three sessions with an interval of 1-3 weeks are usually suffi cient to achieve obliteration of most esophageal varices.
Sclerotherapy is performed using fl exible catheters with a needle tip through which different sclerosants are injected into or next to the varix. Six to eight sessions with an interval of 1-2 weeks are necessary to obliterate the varices. During that time the rebleeding risk is only marginally reduced. Since ligation has replaced sclerotherapy in most situations [2] , variceal injection of sclerosing agents is more or less only used in the emergency situation when ligation cannot be performed. In case of very severe bleeding, particularly from fundal varices, injection of glue such as N-butyl-2-cyanoacrylate may be the method of choice.
Deep ulcers that may lead to bleeding or even perforation are the major problem of injection sclerotherapy.
Prophylaxis of First Bleeding
Patients with liver cirrhosis and large varices should receive prophylactic treatment to prevent bleeding, as there is a possible risk of around 40% of bleeding from their varices within the fi rst 2 years after diagnosis [3] .
Endoscopy is the most sensitive method for detection and risk classifi cation of varices and is therefore the procedure of choice to assess the variceal status [4] . The endoscopic appearance of varices is also part of the most relevant prognostic score for prediction of the individual bleeding risk [5] ( tables 1, 2 ).
During the last 25 years, a nonselective ␤ -blocker, propranolol, has become the standard in prevention of fi rst bleeding [2] , while injection sclerotherapy, which had been evaluated in many controlled trials, is no longer a primary option [7] . The results of this latter approach were too heterogeneous and the method was burdened with too many complications. By contrast, in the last 5 years, endoscopy has become an alternative to ␤ -blockers by using ligation for prophylaxis of fi rst bleeding [8] [9] [10] . According to meta-analyses this is effective when compared to no treatment with a risk reduction of 60% [11] , and it is at least as potent as propranolol [8] [9] [10] ( fi g. 3 ) .
Recurrent varices occur in almost 60% of patients after successful ligation [10] . Therefore, it is important that the The NIEC index is calculated by adding the scores of the three different variables shown. Adapted from NIEC [5] and Jensen [6] . patients undergo regular follow-up visits after initial eradication of the collaterals. Since ligation is more expensive and more invasive, propranolol is still considered the treatment of choice.
Yet, in patients who do not tolerate ␤ -blockers, who have contraindications for medical treatment or who are noncompliant (according to our experience at least 25% of candidates for primary prophylaxis), ligation should be offered as primary prophylaxis [10] . Figure 4 proposes an algorithm for screening, surveillance and primary bleeding prophylaxis in patients with cirrhosis.
Acute Bleeding
Acute variceal bleeding has a poor outcome with a hospital mortality still in the range of 25% [12, 13] . Although bleeding ceases spontaneously in about half of the patients, local endoscopic hemostasis is an important emergency procedure in these patients [2] . It has to be accompanied by other equally important measures, namely, correcting hypovolemia, treatment and prevention of infections and systemic application of vasoactive drugs [14] . With this combined approach, hospital mortality has declined within the last decade, but nevertheless remains high [14] .
A number of small controlled trials suggest that ligation is also superior to sclerotherapy in the emergency situation [15] . However, this is not substantiated by a meta-analysis [16] including all trials. Considering the serious adverse effects caused by large amounts of sclerosant that are required in some cases to stop bleeding, we recommend ligation in the emergency situation whenever possible.
Endoscopic therapy should be paralleled by pharmacologic treatment with vasoactive drugs like somatostatin or terlipressin. Drug treatment should be initiated as early as possible [1] . Several controlled trials underline the value of antibiotic prophylaxis that improves the survival rate of patients with liver cirrhosis admitted to the hospital for intestinal hemorrhage [17, 18] . A quinolone should be administered for at least 7 days.
Prevention of Recurrent Bleeding
After successful management of acute bleeding, an untreated patient has a risk of around 70% to develop a further bleeding episode. Therefore, secondary prophylaxis is mandatory [18] . Several approaches are available: local eradication of varices, shunts, or long-term administration of drugs that reduce portal pressure. All these strategies have been extensively compared in randomised trials [20] . While their effect on rebleeding differs -with shunt procedures being the most effi cient -their impact on improvement of survival is far less clear-cut. It has also been shown that the most potent treatment with respect to rebleeding, namely, placement of a portacaval shunt, bears a rather high risk of mortality, at least in patients with decompensated cirrhosis [21] . Therefore, endoscopy has retained its relevance, especially since introduction of banding ligation [22] .
Sclerotherapy reduces the risk of rebleeding by approximately 40%, similar to the effect of long-term propranolol [23] [24] [25] . However, it has a rather high rate of adverse effects, mainly bleeding ulcers or esophageal stenosis [1] . When obliteration of varices has been achieved, which may take 6-8 weeks, recurrent varices occur less frequently than after ligation. Ligation, however, has several advantages: the rebleeding risk is reduced somewhat more effi ciently (by 30 vs. 40% in sclerotherapy) and the complication rate is signifi cantly lower [21] . The combination of both methods is not superior to ligation alone and the rate of complications is higher [26] , but sclerotherapy may be suitable in very small varices remaining after initial ligation which are not amenable to banding.
When comparing repeated ligation and long-term treatment with a combination of propranolol and nitrates, the results of the randomized trials are heterogeneous [27] [28] [29] . Probably, both methods achieve a similar risk reduction of rebleeding [27] [28] [29] . The combination of both approaches, local eradication of varices and concomitant application of drugs, may achieve the best results. This approach, however, is only based on very few data [30] . Further trials are warranted to evaluate the role of hemodynamic response monitoring in the setting of rebleeding prophylaxis. In Germany, ligation is the primary step in rebleeding prevention followed by transjugular intrahepatic portosystemic shunt (TIPS) in patients with compensated cirrhosis when endoscopy has failed. The role of long-term medical treatment outside studies has possibly not been suffi ciently estimated in the day-today practice since doctors are not convinced that these patients, especially alcoholics, adhere to their medication. An algorithm for the prevention of rebleeding is given in fi gure 5 .
Special Situation (Gastric Varices, Duodenal Varices)
Gastric varices may be the source of bleeding in 3-30% of patients with portal hypertension [31, 32] . These patients have a rather high risk of rebleeding. According to many observational studies, injection of the glue is successful [33] [34] [35] [36] , but a number of serious adverse effects, such as cerebral embolism [37] , have been reported. From the limited controlled data available, injection of glue appears to be the best emergency treatment in patients with bleeding from gastric varices [36] . Ligation and sclerotherapy should not be performed in these patients since size and interconnection of the vessels do not allow immediate obliteration with early serious rebleeding from necrotic ulcers as the possible consequence.
Bleeding from ectopic varices such as duodenal varices account for 1-5% of all bleeding episodes in patients with portal hypertension [38] . Bleeding from duodenal varices is often severe (mortality as high as 40%), and more diffi cult to sclerose than esophageal varices. There are no controlled trials for the treatment of ectopic varices. Treatment options include ligation and sclerotherapy of small ectopic varices, varix embolization and shunt procedures such as TIPS placement, the latter only if patency of the portal vein is given.
Summary
Endoscopy plays a major role in the management of variceal bleeding in portal hypertension.
